The Effect of Action Observation Therapy Including Unimanual and Bimanual Activities in Chronic Stroke

by palligoelme@gmail.com | Jun 9, 2026 | Clinical Trials

​ Conditions: Chronic Stroke Interventions: Other: Action Observation Therapy(unimanuel activities); Other: Action Observation Therapy(bimanuel activities); Other: conventional physiotherapy Sponsors: Karabuk University Recruiting Conditions: Chronic Stroke...

Comparison of Effectiveness and Safety of Tofacitinib Versus Upadacitinib as Add-on to Methotrexate in Rheumatoid Arthritis

by palligoelme@gmail.com | Jun 9, 2026 | Clinical Trials

​ Conditions: Rheumatoid Arthritis (RA) Interventions: Drug: JAK inhibitor(tofacitinib/upadacitinib) as advised by the rheumatologist as add on to 25 mg methotrexate Sponsors: Sheikh Zayed Federal Postgraduate Medical Institute Not yet recruiting Conditions:...

Lomustine Combined With Anlotinib as Interventional Therapy for Extensive-stage Small Cell Lung Cancer Resistant to Second-line and Above Treatment

by palligoelme@gmail.com | Jun 8, 2026 | Clinical Trials

​ Conditions: SCLC, Extensive Stage Interventions: Drug: Lomustine; Drug: Anlotinib Sponsors: Yayi He Not yet recruiting Conditions: SCLC, Extensive Stage Interventions: Drug: Lomustine; Drug: Anlotinib Sponsors: Yayi He Not yet...

Investigating Behavior Change Methods for the Management of Hypertension

by palligoelme@gmail.com | Jun 8, 2026 | Clinical Trials

​ Conditions: Hypertension Interventions: Behavioral: Digital Coaching Plan; Behavioral: Health Awareness Sponsors: Texas A&M University Active, not recruiting Conditions: Hypertension Interventions: Behavioral: Digital Coaching Plan; Behavioral: Health Awareness...

Prospective, Non-interventional Single-arm Study With Tezepelumab to Investigate the Change in Clinical and Patient-reported Outcomes in Patients With CRSwNP in Real-world (PETRICHOR)

by palligoelme@gmail.com | Jun 8, 2026 | Clinical Trials

​ Conditions: Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Sponsors: AstraZeneca Not yet recruiting Conditions: Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Sponsors: AstraZeneca Not yet recruiting 

Becotatug Vedotin Combined With Pucotenlimab for Locally Recurrent Resectable Head and Neck Squamous Cell Carcinoma

by palligoelme@gmail.com | Jun 8, 2026 | Clinical Trials

​ Conditions: Head and Neck Cancer Interventions: Drug: Becotatug Vedotin combined with Pucotenlimab; Procedure: surgery Sponsors: Shanghai Ninth People’s Hospital Affiliated to Shanghai Jiao Tong University Recruiting Conditions: Head and Neck Cancer...